Michelle Rashford

Michelle Rashford is an accomplished medical executive with extensive experience in the pharmaceutical industry, currently serving as Chief Medical Officer at Race Oncology since July 2023. Prior roles include Head of Global Clinical Science at Kyowa Kirin, Inc., and Vice President of Medical Science at Kyowa Kirin NA. Rashford held multiple senior positions at Bristol-Myers Squibb, including Executive Director of Oncology Clinical Development, and has a strong background in medical governance as Responsible Officer at Roche Products. With a medical degree from the University of Tasmania, Rashford has led numerous initiatives in clinical trials, medical affairs, and regulatory compliance throughout a career spanning several decades across leading pharmaceutical companies.